Women at a Disadvantage in Fluorouracil Treatment-Reply

JAMA Oncol. 2016 Jun 1;2(6):830-1. doi: 10.1001/jamaoncol.2016.1089.
No abstract available

MeSH terms

  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology
  • Dihydrouracil Dehydrogenase (NADP) / genetics*
  • Female
  • Fluorouracil / adverse effects*
  • Fluorouracil / therapeutic use
  • Humans
  • Male
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Sex Characteristics

Substances

  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil